Mrs. Navkiran Kaur Brar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4644 |
Dr. Sreelakshmi Kooragayalu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-1200 |
Venumadhav Chirunomula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Hospitalist Department, Cumberland, MD 21502 Phone: 240-964-8564 |
William Davidson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-8720 |
Dr. Haider A Sarraf, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton Memorial Hospita, Easton, MD 21601 Phone: 410-822-1000 |
Pramod Phuyal, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 |
Gopi Manohar C Ponnaganti, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 106 Bow St, Elkton, MD 21921 Phone: 410-398-4000 |
Dr. Sahila Feroz, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 106 Bow St, Elkton, MD 21921 Phone: 410-398-4000 |
Saro Sarkisian, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1562 Opossumtown Pike, Frederick, MD 21702 Phone: 301-662-8477 |
Dr. Minesh Nitinkumar Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 W 7th St, Frederick, MD 21701 Phone: 240-566-3300 |
Dr. Matthew Jerome Boyce, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 655 Watkins Mill Rd, Gaithersburg, MD 20879 Phone: 240-632-4000 |
Dr. Joseph Emmanuel Mcclain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 655 Watkins Mill Rd, Gaithersburg, MD 20879 Phone: 301-848-8790 |
Dr. Douglas Mitchell, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 6934 Aviation Blvd, Suite B, Glen Burnie, MD 21061 Phone: 443-949-0814 |
Dr. Hamid Kiabayan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-787-4527 Fax: 410-595-1992 |
Mohamed Mahmoud Tourky, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6934 Aviation Blvd, Suite B, Glen Burnie, MD 21061 Phone: 443-949-0814 Fax: 443-949-0825 |
Getnet Alemu Tioum, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Hospital Dr, Glen Burnie, MD 21061 Phone: 410-787-4000 |
Mr. Vishwam Rajendrakumar Pandya, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7500 Greenway Center Dr, Ste. 930, Greenbelt, MD 20770 Phone: 301-345-2412 Fax: 301-345-3978 |
Tanvi Tiwari, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 |
Dr. Judith Njomo, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 Fax: 410-884-4643 |
Dr. Emmanuel Kanyi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 11116 Medical Campus Rd, Hagerstown, MD 21742 Phone: 301-790-8804 |
News Archive
Bristol-Myers Squibb today announced the launch of Daklinzaâ–¼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
MiNDERA Corp., a leader in non-invasive molecular diagnostics for dermatology and skin-related cancers, announced today the close of its $1 million Seed financing round. Scientific Health Development and other individual investors are among MiNDERA's new investors. This financing round will enable MINDERA to further validate its proprietary micro-needle technology and prepare for the launch of its first research products.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
› Verified 9 days ago